From 62 Cents To $192 a Share

Editor's Note: Below is a piece from our colleague Jeff Brown regarding a brand new development in the tech space that we think you should take a look at.   Casey Daily Dispatch Reader, Jazz Pharmaceuticals was hemorrhaging cash. Their stock crashed to a low of 62 cents. But then, the FDA pulled this controversial move... And Jazz exploded higher, peaking at $192 a share. An extraordinary 30,867% gain. White I can't promise gains that high, Jazz Pharmaceuticals is not alone. To date, this FDA move has pumped $1.2 trillion into biotechnology companies. It's why Yahoo Finance says biotech is "one of the best performers of the U.S. stock market." And get this... Experts predict another trillion will flood biotech very soon, thanks to this FDA move. I've identified one company I believe will be at the center of this next round of wealth. Click here for the full story. Regards, Jeff Brown Editor, The Near Future Report © Casey Research LLC. All Rights Reserved. 455 NE 5th Ave, Suite D317, Delray Beach, FL 33483 To ensure our emails continue reaching your inbox, please add our email address to your address book. If you no longer wish to hear about this opportunity you can unsubscribe here.